DePuy Hip Recall Issued Due to Metallic Poisoning Danger

This testing will also show the presence of toxic metals in the bloodstream, which will need to be treated.

Johnson & Johnson subsidiary DePuy Orthopedics Inc. issued a recall of all ASR Hip Implant Systems. In May 2010 there were a reported 40,000 DePuy hip implants that were under review, according to the London Times, in Great Britain. This was due to physicians linking the hip replacements with metallic particles, they believed responsible for hip pain, muscle damage, soft tissue damage, vision loss and hearing loss.

In a report released by the National Joint Registry showed the replacement hip had a 13 percent failure rate in the first five years after surgery. It was estimated that one in eight of the hip replacement patients would need to undergo surgery a second time for a new hip replacement.

The National Health Institute of Health published a research report that the hip implant was a faulty device that was necessary to have removed and the patient should be treated for metallic poisoning.

Chromium and cobalt, the heavy metals in the hip replacement were found to enter the circulatory system through the lower part of the hip and acts as a way for toxic debris to enter the bloodstream.

Patients with a hip replacement are urged to visit the physician immediately for comprehensive diagnostic tests to determine if there is hip implant failure damage. This testing will also show the presence of toxic metals in the bloodstream, which will need to be treated.

If you a loved one has suffered from a defective hip replacement device, the hip recall attorneys of Ehline Law will be able to assist you in determining if you have a valid hip recall claim.